1
|
Abstract
INTRODUCTION In the fetus, the ductus venosus (DV) connects the umbilical vein and the portal veins to the inferior vena cava in order to bypass the high-resistance hepatic vascular network. Via the Eustachian valve, the DV directs umbilical venous blood with the highest oxygen content preferentially towards the myocardium and the brain. An absence (agenesis) or a secondary obliteration of an initially normally developed DV (atresia) is associated with various shunt types and may lead to severe hydrops. CASE REPORT A routine check-up of a healthy 34-year-old woman at 27 5/7 wks GA revealed a severe hydrops fetalis with pleural effusions and ascites. After birth at 28 0/7 wks GA, the bilateral pleural effusions needed drainage via thoracic drains. Arterial hypotension was initially treated with volume replacement and dopamine, later on adrenaline and hydrocortisone were added. The initial echocardiography showed normal anatomic structures and normal bi-ventricular function. Despite maximal intensive care treatment, a global respiratory and cardiovascular insufficiency developed. The girl died on fourth day of life. At autopsy, a secondary atresia of the DV was identified, and moreover a pathogenic de novo heterozygous mutation in the KRAS gene was found in the chorion biopsy probe. DISCUSSION For all cases of non-haemolytic hydrops fetalis, a prenatal or postnatal sonography with Doppler examination of the venous system and of the heart should be performed. Furthermore, testing for RASopathies should be recommended especially in presence of increased nuchal translucency thickness and polyhydramnios.
Collapse
Affiliation(s)
- S-E Baller
- Clinic of Neonatology, University Hospital Zurich, Zurich, Switzerland
| | - M Reinehr
- Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland
| | - C Haslinger
- Clinic of Obstetrics, University Hospital Zurich, Zurich, Switzerland
| | - T Restin
- Clinic of Neonatology, University Hospital Zurich, Zurich, Switzerland
| | - J-C Fauchère
- Clinic of Neonatology, University Hospital Zurich, Zurich, Switzerland
| |
Collapse
|
2
|
Affiliation(s)
- C Haslinger
- University Hospital Zurich, Zurich, Switzerland
| |
Collapse
|
3
|
Füeg F, Santos S, Haslinger C, Stoiber B, Schäffer L, Grünblatt E, Zimmermann R, Simões-Wüst AP. Influence of oxytocin receptor single nucleotide sequence variants on contractility of human myometrium: an in vitro functional study. BMC Med Genet 2019; 20:178. [PMID: 31718582 PMCID: PMC6852767 DOI: 10.1186/s12881-019-0894-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 05/17/2019] [Accepted: 09/16/2019] [Indexed: 11/25/2022]
Abstract
Background Oxytocin receptor (OXTR) gene variants have been shown to affect the prevalence of preterm birth, mode of delivery and oxytocin (OXT) requirements for labor induction and augmentation. We hypothesized that this might be associated with different myometrium responses to oxytocin. Our aim was to investigate the influence of a selection of eight OXTR gene single nucleotide variants on oxytocin-induced stimulation of human myometrium contractility in vitro. Methods Human myometrium biopsies were collected during elective cesarean sections at term, if patients had given informed consent. Myometrial strips were submerged under tension in an organ bath and allowed to contract; the remaining material was stored at − 80 °C for further determination of relevant genetics and mRNA level. The area under the curve (AUC) of all contractions taking place in the absence of OXT and of those occurring upon OXT addition (for 30 min each) was measured. OXT stimulation, defined as the ratio between AUC measurements after OXT addition and those in the absence of OXT was calculated for each strip. TaqMan™ Assays were used to detect the allele distribution of the eight OXTR variants and to determine the relative amounts of OXTR-mRNA in the samples. For each variant, oxytocin stimulation of contractility was compared between samples homozygous for the reference allele (reference group) and samples with at least one variant allele (variant group) by linear regression. Results Sixty samples were included in the present study. For rs1042778, rs11706648, rs4686301, rs53576, rs237895, and rs237902, OXT stimulation was similar in the reference and in the variant groups. However, the values of OXT stimulation differed significantly between the reference and the variant groups for rs4686302 (3.1 vs. 4.1 times; p = 0.022) and rs237888 (3.2 vs. 5.5 times; p = 0.001). No significant differences between the levels of OXTR-mRNA in the various reference and corresponding variant groups were detected. Conclusions Patients with variant alleles of rs237888 and/or rs4686302 may be more sensitive to oxytocin stimulation, explaining why these sequence variants have been associated with lower cesarean section prevalence and premature birth, respectively.
Collapse
Affiliation(s)
- F Füeg
- Department of Obstetrics, University Hospital Zurich, Schmelzbergstrasse 12/PF 125, 8091, Zurich, Switzerland
| | - S Santos
- Department of Obstetrics, University Hospital Zurich, Schmelzbergstrasse 12/PF 125, 8091, Zurich, Switzerland
| | - C Haslinger
- Department of Obstetrics, University Hospital Zurich, Schmelzbergstrasse 12/PF 125, 8091, Zurich, Switzerland
| | - B Stoiber
- Department of Obstetrics, University Hospital Zurich, Schmelzbergstrasse 12/PF 125, 8091, Zurich, Switzerland
| | - L Schäffer
- Department of Obstetrics, University Hospital Zurich, Schmelzbergstrasse 12/PF 125, 8091, Zurich, Switzerland
| | - E Grünblatt
- Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.,Neuroscience Centre Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland
| | - R Zimmermann
- Department of Obstetrics, University Hospital Zurich, Schmelzbergstrasse 12/PF 125, 8091, Zurich, Switzerland
| | - A P Simões-Wüst
- Department of Obstetrics, University Hospital Zurich, Schmelzbergstrasse 12/PF 125, 8091, Zurich, Switzerland.
| |
Collapse
|
4
|
Santos S, Haslinger C, Mennet M, von Mandach U, Hamburger M, Simões-Wüst AP. Bryophyllum pinnatum enhances the inhibitory effect of atosiban and nifedipine on human myometrial contractility: an in vitro study. BMC Complement Altern Med 2019; 19:292. [PMID: 31685022 PMCID: PMC6830012 DOI: 10.1186/s12906-019-2711-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/25/2019] [Accepted: 10/10/2019] [Indexed: 12/27/2022]
Abstract
BACKGROUND The herbal medicine Bryophyllum pinnatum has been used as a tocolytic agent in anthroposophic medicine and, recently, in conventional settings alone or as an add-on medication with tocolytic agents such as atosiban or nifedipine. We wanted to compare the inhibitory effect of atosiban and nifedipine on human myometrial contractility in vitro in the absence and in the presence of B. pinnatum press juice (BPJ). METHODS Myometrium biopsies were collected during elective Caesarean sections. Myometrial strips were placed under tension into an organ bath and allowed to contract spontaneously. Test substances alone and at concentrations known to moderately affect contractility in this setup, or in combination, were added to the organ bath, and contractility was recorded throughout the experiments. Changes in the strength (measured as area under the curve (AUC) and amplitude) and frequency of contractions after the addition of all test substances were determined. Cell viability assays were performed with the human myometrium hTERT-C3 and PHM1-41 cell lines. RESULTS BPJ (2.5 μg/mL), atosiban (0.27 μg/mL), and nifedipine (3 ng/mL), moderately reduced the strength of spontaneous myometrium contractions. When BPJ was added together with atosiban or nifedipine, inhibition of contraction strength was significantly higher than with the tocolytics alone (p = 0.03 and p < 0.001, respectively). In the case of AUC, BPJ plus atosiban promoted a decrease to 48.8 ± 6.3% of initial, whereas BPJ and atosiban alone lowered it to 70.9 ± 4.7% and to 80.9 ± 4.1% of initial, respectively. Also in the case of AUC, BPJ plus nifedipine promoted a decrease to 39.9 ± 4.6% of initial, at the same time that BPJ and nifedipine alone lowered it to 78.9 ± 3.8% and 71.0 ± 3.4% of initial. Amplitude data supported those AUC data. The inhibitory effects of BPJ plus atosiban and of BPJ plus nifedipine on contractions strength were concentration-dependent. None of the test substances, alone or in combination, decreased myometrial cell viability. CONCLUSIONS BPJ enhances the inhibitory effect of atosiban and nifedipine on the strength of myometrial contractions, without affecting myometrium tissue or cell viability. The combination treatment of BPJ with atosiban or nifedipine has therapeutic potential.
Collapse
Affiliation(s)
- S. Santos
- Department of Obstetrics, University Hospital Zurich, Schmelzbergstrasse 12/PF 125, 8091 Zurich, Switzerland
- Division of Pharmaceutical Biology, University of Basel, Basel, Switzerland
| | - C. Haslinger
- Department of Obstetrics, University Hospital Zurich, Schmelzbergstrasse 12/PF 125, 8091 Zurich, Switzerland
| | | | - U. von Mandach
- Department of Obstetrics, University Hospital Zurich, Schmelzbergstrasse 12/PF 125, 8091 Zurich, Switzerland
| | - M. Hamburger
- Division of Pharmaceutical Biology, University of Basel, Basel, Switzerland
| | - A. P. Simões-Wüst
- Department of Obstetrics, University Hospital Zurich, Schmelzbergstrasse 12/PF 125, 8091 Zurich, Switzerland
| |
Collapse
|
5
|
Haslinger C, Fiedler A, Brun R, Randegger D, Balsyte D, Zimmermann R. Effect of delayed pushing on postpartum blood loss in nulliparous women with epidural analgesia. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- C Haslinger
- Division of Obstetrics, University Hospital of Zurich, Zürich, Schweiz
| | - A Fiedler
- Division of Obstetrics, University Hospital of Zurich, Zürich, Schweiz
| | - R Brun
- Division of Obstetrics, University Hospital of Zurich, Zürich, Schweiz
| | | | - D Balsyte
- Division of Obstetrics, University Hospital of Zurich, Zürich, Schweiz
| | - R Zimmermann
- Division of Obstetrics, University Hospital of Zurich, Zürich, Schweiz
| |
Collapse
|
6
|
Kahr MK, Franke D, Brun R, Wisser J, Zimmermann R, Haslinger C. Blood group O: A novel risk factor for increased postpartum blood loss? Haemophilia 2018; 24:e207-e212. [PMID: 29877601 DOI: 10.1111/hae.13537] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/04/2018] [Indexed: 01/19/2023]
Abstract
INTRODUCTION Blood group O is known to be associated with lower levels of von Willebrand factor (VWF) and with increased bleeding complications. The influence of blood group O on postpartum blood loss was assessed by a few studies, however, without adjustment for important obstetric risk factors for postpartum blood loss. AIM Aim of this study was to investigate whether women with blood group O exhibit increased blood loss after delivery in consideration of established risk factors for postpartum bleeding. METHODS A total of 1487 patients were prospectively included into this cohort study. Blood loss was assessed by estimated blood loss (in mL), and drop of haemoglobin (Δ haemoglobin) was calculated. Association of blood loss with risk factors (such as blood group O, cervical tears, morbidly adherent placenta, placenta praevia and uterine atony amongst others) was assessed with appropriate tests. Significant variables were entered into a stepwise multivariate regression analysis. RESULTS Women with blood group O showed a significantly higher blood loss when compared to women with blood group non-O (529.2 mL ± 380.4 mL and 490.5 mL ± 276.4 mL, respectively, P = .024)). The increased blood loss in women with blood group O remained significant after multivariate regression analysis (difference 47 mL, P = .019). CONCLUSION This is the first study reporting significantly increased blood loss following delivery in women with blood group O after adjustment for major risk factors for postpartum blood loss. Albeit having a statistically significant, but clinically minor effect on absolute blood loss, blood group O carriers may suffer from aggravated bleeding in the presence of additional obstetric bleeding pathologies.
Collapse
Affiliation(s)
- M K Kahr
- Division of Obstetrics, University Hospital of Zürich, Zürich, Switzerland
| | - D Franke
- Division of Obstetrics, University Hospital of Zürich, Zürich, Switzerland
| | - R Brun
- Division of Obstetrics, University Hospital of Zürich, Zürich, Switzerland
| | - J Wisser
- Division of Obstetrics, University Hospital of Zürich, Zürich, Switzerland
| | - R Zimmermann
- Division of Obstetrics, University Hospital of Zürich, Zürich, Switzerland
| | - C Haslinger
- Division of Obstetrics, University Hospital of Zürich, Zürich, Switzerland
| |
Collapse
|
7
|
Haslinger C, Bamert H, Rauh M, Burkhardt T, Schäffer L. Effect of maternal smoking on stress physiology in healthy neonates. J Perinatol 2018; 38:132-136. [PMID: 29120451 DOI: 10.1038/jp.2017.172] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/06/2017] [Revised: 08/18/2017] [Accepted: 09/21/2017] [Indexed: 01/07/2023]
Abstract
OBJECTIVE To assess the impact of maternal smoking during pregnancy (MSDP) on the neonatal hypothalamic-pituitary-adrenal axis. STUDY DESIGN In a prospective observational study, salivary cortisol and cortisone levels were measured at the fourth day of life during resting conditions and in response to a pain-induced stress event in healthy neonates whose mothers smoked cigarettes during each stage of pregnancy and compared with controls. RESULTS Neonates in the control group (n=70) exhibited a physiologic stress response with a significant increase in cortisol (1.3 to 2.1 ng ml-1; P<0.05) and cortisone (11.8 to 17.8 ng ml-1; P<0.05) from baseline levels, whereas in neonates from mothers who smoked (n=33), cortisol (0.9 to 0.8 ng ml-1; P=0.77) and cortisone (11.5 to 13.0; P=0.19) stress response was not significantly different from baseline levels. A two-way analysis of variance confirmed these findings in both groups. CONCLUSIONS Healthy neonates whose mothers smoked during pregnancy show a blunted stress response on the fourth day of life. Thus, MSDP leads to a dysregulation of the HPA axis with continued effects in neonatal life. This might explain long-term consequences of MSDP such as overweight, diabetes mellitus and modification of blood pressure control mechanisms in adult life.
Collapse
Affiliation(s)
- C Haslinger
- Division of Obstetrics, University Hospital of Zürich, Zürich, Switzerland
| | - H Bamert
- Division of Obstetrics, University Hospital of Zürich, Zürich, Switzerland
| | - M Rauh
- Division of Pediatrics, University Hospital of Erlangen, Erlangen, Germany
| | - T Burkhardt
- Division of Obstetrics, University Hospital of Zürich, Zürich, Switzerland
| | - L Schäffer
- Division of Obstetrics, Kantonsspital Baden, Baden, Switzerland
| |
Collapse
|
8
|
Santos S, Haslinger C, Hamburger M, Mennet M, Potterat O, Schnelle M, Mandach U, Simões-Wüst AP. In vitro effect on myometrial contractility by a combination of Bryophyllum pinnatum juice and atosiban. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- S Santos
- Department of Obstretics, University Hospital Zürich, Zürich, Switzerland
- Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
| | - C Haslinger
- Department of Obstretics, University Hospital Zürich, Zürich, Switzerland
| | - M Hamburger
- Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
| | - M Mennet
- Clinical Research, Weleda AG, Arlesheim, Switzerland
| | - O Potterat
- Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
| | - M Schnelle
- Clinical Research, Weleda AG, Arlesheim, Switzerland
| | - U Mandach
- Department of Obstretics, University Hospital Zürich, Zürich, Switzerland
| | - AP Simões-Wüst
- Department of Obstretics, University Hospital Zürich, Zürich, Switzerland
| |
Collapse
|
9
|
Kimmich N, Haslinger C, Juhasova J, Ochsenbein-Kölble N, Zimmermann R. Höhenstandsänderung des fetalen Kopfes und deren Einflussfaktoren in der aktiven Phase der Geburt: eine retrospektive Kohortenstudie. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
10
|
Dedes I, Schäffer L, Zimmermann R, Burkhardt T, Haslinger C. Outcome and risk factors of cesarean delivery with and without cesarean myomectomy in women with uterine myomatas. Arch Gynecol Obstet 2016; 295:27-32. [DOI: 10.1007/s00404-016-4177-8] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2016] [Accepted: 08/09/2016] [Indexed: 10/21/2022]
|
11
|
Dedes I, Schäffer L, Zimmermann R, Haslinger C. Evaluation of myomectomy during cesarean delivery in patients with uterus myomatosus. Z Geburtshilfe Neonatol 2015. [DOI: 10.1055/s-0035-1566514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
12
|
Furrer R, Winter K, Zimmermann R, Schäffer L, Haslinger C. Peripartal blood loss and outcome of intrahepatic cholestasis of pregnancy. Z Geburtshilfe Neonatol 2015. [DOI: 10.1055/s-0035-1566602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
13
|
Furrer R, Schäffer L, Zimmermann R, Haslinger C. Maternal and fetal outcome after fundal uterine pressure (Kristeller maneuver) in spontaneous and assisted vaginal deliveries. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
14
|
Stoiber B, Haslinger C, Schäffer MK, Zimmermann R, Schäffer L. Dual tocolysis with fenoterol and atosiban in human myometrium demonstrates additive effect in vitro. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
15
|
Sturzenegger K, Schäffer L, Zimmermann R, Haslinger C. Risikofaktoren der Uterusruptur – eine retrospektive Analyse von 20152 Geburten. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
16
|
Rupp C, Scherzer M, Rudisch A, Unger C, Haslinger C, Schweifer N, Artaker M, Nivarthi H, Moriggl R, Hengstschläger M, Kerjaschki D, Sommergruber W, Dolznig H, Garin-Chesa P. IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor-stroma interaction. Oncogene 2014; 34:815-25. [PMID: 24632618 DOI: 10.1038/onc.2014.18] [Citation(s) in RCA: 81] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2013] [Revised: 12/26/2013] [Accepted: 01/31/2014] [Indexed: 02/07/2023]
Abstract
The activated tumor stroma participates in many processes that control tumorigenesis, including tumor cell growth, invasion and metastasis. Cancer-associated fibroblasts (CAFs) represent the major cellular component of the stroma and are the main source for connective tissue components of the extracellular matrix and various classes of proteolytic enzymes. The signaling pathways involved in the interactions between tumor and stromal cells and the molecular characteristics that distinguish normal 'resting' fibroblasts from cancer-associated or '-activated' fibroblasts remain poorly defined. Recent studies emphasized the prognostic and therapeutic significance of CAF-related molecular signatures and a number of those genes have been shown to serve as putative therapeutic targets. We have used immuno-laser capture microdissection and whole-genome Affymetrix GeneChip analysis to obtain transcriptional signatures from the activated tumor stroma of colon carcinomas that were compared with normal resting colonic fibroblasts. Several members of the Wnt-signaling pathway and gene sets related to hypoxia, epithelial-to-mesenchymal transition (EMT) and transforming growth factor-β (TGFβ) pathway activation were induced in CAFs. The putative TGFβ-target IGFBP7 was identified as a tumor stroma marker of epithelial cancers and as a tumor antigen in mesenchyme-derived sarcomas. We show here that in contrast to its tumor-suppressor function in epithelial cells, IGFPB7 can promote anchorage-independent growth in malignant mesenchymal cells and in epithelial cells with an EMT phenotype when IGFBP7 is expressed by the tumor cells themselves and can induce colony formation in colon cancer cells co-cultured with IGFBP7-expressing CAFs by a paracrine tumor-stroma interaction.
Collapse
Affiliation(s)
- C Rupp
- Clinical Institute for Pathology, Medical University of Vienna, Vienna, Austria
| | - M Scherzer
- Institute of Medical Genetics, Center of Pathobiology and Genetics, Medical University of Vienna, Vienna, Austria
| | - A Rudisch
- Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
| | - C Unger
- Institute of Medical Genetics, Center of Pathobiology and Genetics, Medical University of Vienna, Vienna, Austria
| | - C Haslinger
- Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
| | - N Schweifer
- Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
| | - M Artaker
- Max F. Perutz Laboratories, Medical University of Vienna, Vienna, Austria
| | - H Nivarthi
- Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria
| | - R Moriggl
- Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria
| | - M Hengstschläger
- Institute of Medical Genetics, Center of Pathobiology and Genetics, Medical University of Vienna, Vienna, Austria
| | - D Kerjaschki
- Clinical Institute for Pathology, Medical University of Vienna, Vienna, Austria
| | | | - H Dolznig
- Institute of Medical Genetics, Center of Pathobiology and Genetics, Medical University of Vienna, Vienna, Austria
| | - P Garin-Chesa
- 1] Clinical Institute for Pathology, Medical University of Vienna, Vienna, Austria [2] Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
| |
Collapse
|
17
|
Haslinger C, Stoiber B, Zimmermann R, Schäffer L. Erhöhte Schwangerschaftsrisiken bei weit fortgeschrittenem mütterlichem Alter über 45 Jahre (VAMA). Z Geburtshilfe Neonatol 2013. [DOI: 10.1055/s-0033-1361226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
18
|
Voelckel WG, Klima G, Krismer A, Haslinger C, Stadlbauer K, Wenzel V, von Goedecke A. Does Excessive ???Searching??? Increase the Risk of Neural Trauma in Peripheral Nerve Blockade? Anesth Analg 2006. [DOI: 10.1213/01.ane.0000227149.07877.d5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
19
|
Affiliation(s)
- C. Haslinger
- Organisches Laboratorium der Techn. Hochschule zu Berlin
| |
Collapse
|
20
|
Affiliation(s)
- C. Haslinger
- Organisches Laboratorium der Technischen Hochschule zu Berlin
| |
Collapse
|
21
|
Vinatzer U, Dampier B, Pacher M, Kaserer K, Haslinger C, Schweifer N, Schreiber M. Genome-wide expression profiling of microdissected human breast tumor cells: tumor classification predictive of metastases and clinical outcome. Breast Cancer Res 2005. [PMCID: PMC4233580 DOI: 10.1186/bcr1159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
22
|
Haslinger C. Die chemische Industrie in den Oststaaten der nordamerikanischen Union. Angew Chem Int Ed Engl 1911. [DOI: 10.1002/ange.19110241802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
23
|
Haslinger C. Die chemische Industrie in den Oststaaten der nordamerikanischen Union. Angew Chem Int Ed Engl 1911. [DOI: 10.1002/ange.19110241504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
24
|
Haslinger C. Die chemische Industrie in den Oststaaten der nordamerikanischen Union. Angew Chem Int Ed Engl 1911. [DOI: 10.1002/ange.19110241402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|